Accera Secures $35,000,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=629c3feb-f483-45f5-a49c-29ad47ee7ac7&Preview=1 - Date
5/8/2013 - Company Name
Accera - Mailing Address
380 Interlocken Crescent Broomfield, CO 80021 - Company Description
Accera is a private biotechnology company engaged in the discovery and development of innovative therapeutic treatments for neurodegenerative diseases. - Website
http://www.accerapharma.com - Transaction Type
Debt, Venture Equity - Transaction Amount
$35,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
